Acquired reactive perforating collagenosis in a patient with lung fibrosis

Journal of Dermatology

Volumn 31, Issue 11, 2004, Pages 916-919

  Tsuboi, Hiromi ^a   Mukuno, Akira ^a   Sato, Naoya ^a   Katsuoka, Kensei ^a   Yanase, Nobuo ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acquired reactive perforating collagenosis; Lung fibrosis; Reactive perforating collagenosis

Indexed keywords

DAPSONE; PREDNISOLONE; STEROID; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CANCER; CASE REPORT; COLLAGEN DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; KIDNEY DISEASE; LUNG FIBROSIS; MALE; PAPULAR SKIN DISEASE; PRURITUS; REACTIVE PERFORATING COLLAGENOSIS;

EID: 10044292754     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00626.x     Document Type: Article

References (16)

1. Seghal VN, Jain S, Thappa DM, et al: Perforating dermatosis: A review and report of four cases, J Dermatol, 20: 329-330, 1993.
2. Penas PF, Jones-Caballero M, Fraga J, et al: Perforating granuloma annulare, Int J Dermatol, 36: 340-348, 1997.
3. Faver IR, Daoud MS, Su WP: Acquired reactive perforating collagenosis: Report of six cases and review of the literature, Am Acad Dermatol, 30: 575-580, 1994.
4. Kim JH, Kang WH: Acquired reactive perforating collagenosis in a diabetic patient with pulmonary aspergillosis, Cutis, 66: 425-430, 2000.
5. Kawakami T, Soma Y, Mizoguchi M, et al: Immunohistochemical analysis of transforming growth factor beta 3 expression in acquired reactive perforating collagenosis, Br J Dermatol, 144: 197-199, 2001.
6. Kenyon NJ, Ward RW, McGrew G, et al: TGF-beta 1 causes airway fibrosis and increased collagen I and collagen III mRNA in mice, Thorax, 58: 772-777, 2003.
7. Beck HI, Brandrup F, Hangdrup HK, et al: Adult, acquired reactive perforating collagenosis, Report of a case including ultrastructural findings, J Cutan Pathol, 15: 124-128, 1988.
8. Patterson JW: The perforating disorders, J Am Acad Dermatol, 10: 561-581, 1984.
9. Kawakami T, Saito R: Acquired reactive perforating collagenosis associated with diabetes mellitus: Eight cases that meet Paver's criteria, Br J Dermatol, 140: 521-524, 1999.
10. Zhang Y, McCormick LL, Desai SR, et al: Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: Cutaneous cytokines, chemokines, and immune cell activation, J Immunol, 168: 3088-3098, 2002.
11. Zhang Y, McCormick LL, Gilliam AC: Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus host disease, a model for human scleroderma, J Invest Dermatol, 121: 713-719, 2003.
12. McCormick LL, Zhang Y, Tootell E, Gilliam AC: Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: A model for human scleroderma, J Immunol, 15: 163: 5693-1600, 1999.
13. Brinkmeier T, Schaller J, Herbst RA, et al: Successful treatment of acquired reactive perforating collagenosis with doxycycline, Acta Derm Venereal, 82: 393-395, 2002.
14. Querings K, Balda BR, Bachter D: Treatment of acquired reactive perforating collagenosis with allopurinol, Br J Dermatol, 145: 174, 2001.
15. Vion B, Frenk E: Acquired reactive collagen disease in the adult: Successful treatment with UV-B light, Hautarzt, 40: 448-450, 1989.
16. Serrano G, Aliaga A, Lorente M: Reactive perforating collagenosis responsive to PUVA, Int J Dermatol, 27: 118-119, 1988.